These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38104782)

  • 1. Predictive factors for severe radiation-induced lung injury in patients with lung cancer and coexisting interstitial lung disease.
    Park SH; Lim JK; Kang MK; Park J; Hong CM; Kim CH; Cha SI; Lee J; Lee SJ; Kim JC
    Radiother Oncol; 2024 Mar; 192():110053. PubMed ID: 38104782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review.
    Saha A; Dickinson P; Shrimali RK; Salem A; Agarwal S
    Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):e493-e504. PubMed ID: 35168842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis.
    Szejniuk WM; Nielsen MS; Takács-Szabó Z; Pawlowski J; Al-Saadi SS; Maidas P; Bøgsted M; McCulloch T; Frøkjær JB; Falkmer UG; Røe OD
    Radiat Oncol; 2021 Jul; 16(1):131. PubMed ID: 34266462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation pneumonitis after palliative radiotherapy in cancer patients with interstitial lung disease.
    Okumura M; Hojo H; Nakamura M; Hiyama T; Nakamura N; Zenda S; Motegi A; Hirano Y; Kageyama SI; Parshuram RV; Fujisawa T; Kuno H; Akimoto T
    Radiother Oncol; 2021 Aug; 161():47-54. PubMed ID: 34089755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease.
    Bahig H; Filion E; Vu T; Chalaoui J; Lambert L; Roberge D; Gagnon M; Fortin B; Béliveau-Nadeau D; Mathieu D; Campeau MP
    Pract Radiat Oncol; 2016; 6(5):367-374. PubMed ID: 27068780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy.
    Li F; Liu H; Wu H; Liang S; Xu Y
    Radiat Oncol; 2021 Apr; 16(1):70. PubMed ID: 33849579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
    Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
    Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus and radiation induced lung injury after thoracic stereotactic body radiotherapy.
    Kalman NS; Hugo GD; Mahon RN; Deng X; Mukhopadhyay ND; Weiss E
    Radiother Oncol; 2018 Nov; 129(2):270-276. PubMed ID: 30253874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-lymphocyte ratio and a dosimetric factor for predicting symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
    Lee YH; Choi HS; Jeong H; Kang KM; Song JH; Lee WS; Lee GW; Song HN; Kim HG; Kang MH; Rhee DY; Jeong BK
    Clin Respir J; 2018 Mar; 12(3):1264-1273. PubMed ID: 28618180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric factors and Lyman normal-tissue complication modelling analysis for predicting radiation-induced lung injury in postoperative breast cancer radiotherapy: a prospective study.
    Zhou ZR; Han Q; Liang SX; He XD; Cao NY; Zi YJ
    Oncotarget; 2017 May; 8(20):33855-33863. PubMed ID: 27806340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis.
    Yamaguchi S; Ohguri T; Ide S; Aoki T; Imada H; Yahara K; Narisada H; Korogi Y
    Lung Cancer; 2013 Nov; 82(2):260-5. PubMed ID: 24054547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.
    Li F; Zhou Z; Wu A; Cai Y; Wu H; Chen M; Liang S
    Radiat Oncol; 2018 May; 13(1):82. PubMed ID: 29716649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease.
    Liu Y; Zhu Y; Wu R; Hu M; Zhang L; Lin Q; Weng D; Sun X; Liu Y; Xu Y
    Transl Lung Cancer Res; 2020 Dec; 9(6):2328-2336. PubMed ID: 33489796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients.
    Saha A; Beasley M; Hatton N; Dickinson P; Franks K; Clarke K; Jain P; Teo M; Murray P; Lilley J
    Radiother Oncol; 2021 Mar; 156():153-159. PubMed ID: 33333139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer.
    Han S; Gu F; Lin G; Sun X; Wang Y; Wang Z; Lin Q; Weng D; Xu Y; Mao W
    J Cancer; 2015; 6(11):1172-8. PubMed ID: 26516366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early, non-invasive detection of radiation-induced lung injury using PET/CT by targeting CXCR4.
    Pei J; Cheng K; Liu T; Gao M; Wang S; Xu S; Guo Y; Ma L; Li W; Wang B; Yu J; Liu J
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1109-1120. PubMed ID: 38030744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.
    Nakajima M; Yamamoto N; Hayashi K; Karube M; Ebner DK; Takahashi W; Anzai M; Tsushima K; Tada Y; Tatsumi K; Miyamoto T; Tsuji H; Fujisawa T; Kamada T
    Radiat Oncol; 2017 Sep; 12(1):144. PubMed ID: 28865463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer.
    Ueki N; Matsuo Y; Togashi Y; Kubo T; Shibuya K; Iizuka Y; Mizowaki T; Togashi K; Mishima M; Hiraoka M
    J Thorac Oncol; 2015 Jan; 10(1):116-25. PubMed ID: 25376512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combing NLR, V20 and mean lung dose to predict radiation induced lung injury in patients with lung cancer treated with intensity modulated radiation therapy and chemotherapy.
    Pan WY; Bian C; Zou GL; Zhang CY; Hai P; Zhao R; Wang YY
    Oncotarget; 2017 Oct; 8(46):81387-81393. PubMed ID: 29113398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury.
    Cella L; Liuzzi R; D'Avino V; Conson M; Di Biase A; Picardi M; Pugliese N; Solla R; Salvatore M; Pacelli R
    Acta Oncol; 2014 May; 53(5):613-9. PubMed ID: 24195693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.